Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1574 participants.
Also called NCT07601763
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,574 participants
- Registry
-
NCT07601763
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07601763. Randomized; single masking; primary purpose treatment. Start 2025-04-16 (actual); primary completion 2027-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF)
- Acronym
- POWER-AF
- Condition
- Atrial Fibrillation (AF)
- Condition
- Atrial Fibrillation Ablation
- Condition
- Atrial Fibrillation Recurrent
- Condition
- Pulsed Field Ablation
- Condition
- Radiofrequency Catheter Ablation
- Intervention (Procedure)
- Pulsed field ablation
- Intervention (Procedure)
- Radiofrequency ablation alone
- Intervention (Device)
- Pulsed field ablation system
- Lead sponsor
- China National Center for Cardiovascular Diseases
Record details
- Record id
cardio:ct-nct07601763- Content hash
0cede7f284cc13158c64a40d07c21188681c67987ffaecce0f96697993081c06